Cargando…
Remodeling an existing rare disease registry to be used in regulatory context: Lessons learned and recommendations
Disease registries have been used as an interesting source of real-world data for supporting regulatory decision-making. In fact, drug studies based on registries cover pre-approval investigation, registry randomized clinical trials, and post-authorization studies. This opportunity has been investig...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537464/ https://www.ncbi.nlm.nih.gov/pubmed/36210847 http://dx.doi.org/10.3389/fphar.2022.966081 |